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Abstract
Melanoma is the most serious type of skin disease and a leading cause of death from skin disease due to its highly
metastatic ability. To develop more effective chemopreventive agents for the prevention of melanoma, we have determined
the effect of green tea catechins on the invasive potential of human melanoma cells and the molecular mechanisms
underlying these effects using A375 (BRAF-mutated) and Hs294t (Non-BRAF-mutated) melanoma cell lines as an in vitro
model. Employing cell invasion assays, we found that the inhibitory effects of green tea catechins on the cell migration were
in the order of (-)-epigallocatechin-3-gallate (EGCG).(-)-epigallocatechin.(-)-epicatechin-3-gallate.(-)-gallocatechin.(-)-
epicatechin. Treatment of A375 and Hs294t cells with EGCG resulted in a dose-dependent inhibition of cell migration or
invasion of these cells, which was associated with a reduction in the levels of cyclooxygenase (COX)-2, prostaglandin (PG) E2
and PGE2 receptors (EP2 and EP4). Treatment of cells with celecoxib, a COX-2 inhibitor, also inhibited melanoma cell
migration. EGCG inhibits 12-O-tetradecanoylphorbol-13-acetate-, an inducer of COX-2, and PGE2-induced cell migration of
cells. EGCG decreased EP2 agonist (butaprost)- and EP4 agonist (Cay10580)-induced cell migration ability. Moreover, EGCG
inhibited the activation of NF-kB/p65, an upstream regulator of COX-2, in A375 melanoma cells, and treatment of cells with
caffeic acid phenethyl ester, an inhibitor of NF-kB, also inhibited cell migration. Inhibition of melanoma cell migration by
EGCG was associated with transition of mesenchymal stage to epithelial stage, which resulted in an increase in the levels of
epithelial biomarkers (E-cadherin, cytokeratin and desmoglein 2) and a reduction in the levels of mesenchymal biomarkers
(vimentin, fibronectin and N-cadherin) in A375 melanoma cells. Together, these results indicate that EGCG, a major green
tea catechin, has the ability to inhibit melanoma cell invasion/migration, an essential step of metastasis, by targeting the
endogenous expression of COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
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Introduction
The melanoma remains the leading cause of death from skin
diseases due to its propensity to metastasis. The statistical analysis
from American Cancer Society indicated that in 2008, there were
8,420 melanoma-associated deaths in the U.S. and the number of
new cases of invasive melanoma was estimated at 62,480 [1]. The
incidence of melanoma has increased in the past few decades in
the United States and is increasing rapidly in children [1–3]. If
recognized and treated early, melanoma is curable, but as the
disease progresses its propensity to metastasize make it difficult to
treat. Chronic exposure to solar ultraviolet (UV) radiation has
been implicated in melanoma and non-melanoma skin cancers
[4,5]. Exposure of the skin to UV radiation induces an increase in
the expression levels of cyclooxygenase-2 (COX-2), a rate-limiting
enzyme that catalyzes the conversion of arachidonic acid to
prostaglandins (PGs). The enhanced generation of PGs, specifi-
cally PGE2, plays a central role in orchestrating the multiple events
involved in cancer invasion and metastasis. PGE2 is an important
metabolite which has been implicated in these risks more than
other PG metabolites, and has been shown to exert its effects
through G protein-coupled receptors, EP1, EP2, EP3 and EP4,
and has been implicated in angiogenesis, decreased host immunity
and enhanced invasion and metastasis [6,7]. Although, melanoma
is less common than other skin cancers, it causes the majority
(75%) of skin cancer-related deaths. Once diagnosed with
metastatic melanoma, most patients will die of their disease within
2 years [1,8]. Since, melanoma is a highly malignant cancer with a
potent capacity to metastasize distantly, an approach that reduces
its metastatic ability may facilitate the development of an effective
strategy for its treatment and/or prevention.
Catechins isolated from the leaves of green tea (Camellia sinensis)
have a number of beneficial health effects including anti-
carcinogenic activity, which has been demonstrated in various
tumor models [9,10]. In previous studies, we and others have
shown that oral administration of an aqueous extract of green tea
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(a mixture of catechins), in drinking water inhibits UV radiation-
induced non-melanoma skin cancer in mice in terms of tumor
incidence, tumor multiplicity and tumor growth/size [11,12].
Multiple mechanisms or molecular targets have been reported by
which green tea polyphenols protect the skin from skin tumors.
These mechanisms include the DNA repair [13,14], stimulation of
immune system [14,15], anti-inflammatory effects [16] and anti-
oxidant activity [17] of green tea polyphenols in vitro and in vivo
models. However, the beneficial effects of green tea polyphenols
on melanoma are not well studied and less understood. As green
tea is commonly consumed as a beverage world-wide, we assessed
the effect of its polyphenolic components on the invasive potential
of melanoma cells using melanoma cell lines as an in vitro model.
Beverage grade green tea leaves contains 5 major catechins or
epicatechin derivatives: (-)-epicatechin, (-)-gallocatechin, (-)-epica-
techin gallate, (-)-epigallaocatechin and (-)-epigallocatechin-3-
gallate (EGCG) [18].
In the present study, first we assessed the chemotherapeutic
potential of various catechins on the migration capacity of human
melanoma cells, as the migration of cancer cells is a major event in
the metastatic cascade. For this purpose, two highly metastasis-
specific melanomacancercell lineswereselected:oneisA375 which
is BRAF mutated and activating mutations of the protooncogene
BRAF have been observed in approximately 50% of malignant
melanomas. Second cell line is Hs294t, which is also highly
metastatic but not BRAF mutated. These two cell lines were used as
an in vitro model for this study. In preliminary screening
experiments, we identified that EGCG is a major active component
of green tea polyphenols which significantly blocks the migration/
invasion of melanoma cells compared to other catechins or
epicatechin derivatives. We further characterized the role of
COX-2 and its metabolite PGE2 on the migration of human
melanoma cancer cells and ascertained whether EGCG has any
suppressive effects on the COX-2-mediated migration of these cells.
Epithelial-to-mesenchymal transition (EMT), the process whereby
epithelial cells transform into mesenchymal cells, has recently been
shown to be relevant for cancer growth and cancer metastasis.
During EMT, cells lose expression of proteins that promote cell-cell
contact such as E-cadherin and acquire mesenchymal markers such
as vimentin, fibronectin and N-cadherin, which promote cell
invasion and metastasis [19]. The EMT has also been associated
with higher levels of inflammation and inflammatory mediators,
and therefore we have also checked whether inhibition of COX-2
expression and PGE2 production by EGCG in melanoma cells is
associated with reversal of EMT and that leads to inhibitory effect
onmelanomacellmigration.Here,wepresentevidencethat EGCG
inhibits the invasive potential of melanoma cells through transition
of mesenchymal state to epithelial state in melanoma cells and that
EGCG do sothrough a process that involves the reductionofCOX-
2 expression and lowering the levels of PGE2 and PGE2 receptors in
melanoma cells.
Materials and Methods
Source of green tea catechins
Various purified tea catechins used in this study were obtained
from Dr. Y. Hara of Mitsui Norin Company (Tokyo, Japan).
These catechins or polyphenols are stable for at least two years
when refrigerated at 4uC.
Antibodies, chemicals and reagents
Celecoxib, PGE2, 12-O-tetradecanoylphorbol-13-acetate (TPA)
and EP2 agonist were purchased from Sigma Chemical Co. (St.
Louis, MO). Boyden Chambers and polycarbonate membranes
(8 mm pore size) for cell invasion assays were obtained from
Neuroprobe, Inc. (Gaithersburg, MD). The antibodies specific to
N-cadherin, keratin-18 and fibronectin were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA), while antibodies for EP1,
EP2, EP3, EP4, vimentin, E-cadherin, NF-kB, IKKa and IkBa
and their secondary antibodies were purchased from Cell
Signaling Technology (Beverly, MA). Desmoglein-2 was obtained
from Abcam (Cambridge, MA). Antibodies specific for COX-2,
EP4 agonist and an enzyme immunoassay kit for PGE2 analysis
were obtained from Cayman Chemicals (Ann Arbor, MI).
Cell lines and cell culture conditions
The normal human epidermal melanocytes (HEMa-LP,
Catalogue #C-024-5C) were commercially obtained from Invi-
trogen (Carlsbad, CA), and were cultured in HMGS-2 medium
supplemented with human melanocyte growth supplement
provided by the supplier. The human melanoma cells lines,
A375 and Hs294t, were purchased from the American Type
Culture Collection (Manassas, VA). The cell lines were cultured as
monolayers in RPMI 1640 culture medium supplemented with
10% heat-inactivated fetal bovine serum (Hyclone, Logan, UT),
100 mg/mL penicillin, and 100 mg/mL streptomycin and main-
tained in an incubator with 5% CO2 at 37uC. The EGCG was
dissolved in a small amount of acetone, which was added to the
complete cell culture medium [maximum concentration of
acetone, 0.1% (v/v) in media] prior to addition to sub-confluent
cells (60–70% confluent). Cells treated with acetone only served as
a vehicle control. To determine the effect of EGCG on TPA- or
PGE2-mediated effects, EGCG was added in cell culture medium
at least 30 minutes before the treatment of the cells with TPA,
PGE2, PGE2 receptor or PGE2 receptor agonists.
Cell invasion assay
The invasion capacity of melanoma cells was determined in vitro
using Boyden Chambers (Gaithersburg, MD) in which the two
chambers were separated with matrigel coated Millipore mem-
branes (6.5 mm diameter filters, 8 mM pore size), as detailed
previously [20]. Briefly, melanoma cells (1.5610
4 cells/100 mL
serum-reduced medium) were placed in the upper chamber of
Boyden chambers, test agents were added alone, or in combina-
tion, to the upper chamber (200 mL), and the lower chamber
contained the medium alone (150 mL). Chambers were assembled
and kept in an incubator for 24 h. After incubation, cells from the
upper surface of Millipore membranes were removed with gentle
swabbing and the migrant cells on the lower surface of membranes
were fixed and stained with crystal violet. Membranes were then
washed with distilled water and mounted onto glass slides. The
membranes were examined microscopically and cellular migration
was determined by counting the number of stained cells on each
membrane in at least 4–5 randomly selected fields using an
Olympus BX41 microscope. Representative photomicrographs
were obtained using a Qcolor5 digital camera system fitted to an
Olympus BX41 microscope. Resultant data are presented as a
mean of migrating cells 6 SD/microscopic field of three
independent experiments.
Scratch assay or wound healing assay
Scratch or wound healing assay was performed to detect
melanoma cell migration, as detailed previously [20]. Briefly,
melanoma cells were grown to full confluency in six-well plates
and incubated overnight in starvation medium. Cell monolayers
were wounded with a sterile 100 mL pipette tip, washed with
starvation medium to remove detached cells from the plates. Cells
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catechins in full medium and kept in a CO2 incubator for 48 h.
After 48 h, medium was replaced with phosphate-buffered saline
(PBS) buffer, the wound gap was observed and cells were
photographed using an Olympus BX41 microscope fitted with
digital camera.
Quantitation of prostaglandin E2 using PGE2
immunoassay kit
The levels of PGE2 in cell homogenates were measured using
the Cayman PGE2 Enzyme Immunoassay Kit (Ann Arbor, MI)
following the manufacturer’s protocol. Briefly, at indicated time
point, cells were harvested and homogenized in 100 mM
phosphate buffer, pH 7.4 containing 1 mM ethylenediamine
tetraacetic acid and 10 mM indomethacin using a homogenizer.
Homogenates were centrifuged and the supernatants were
collected for the analysis of PGE2 concentrations following the
manufacturer’s protocol.
Western blot analysis
Cell lysates were prepared to analyze the expression levels of
different proteins, as described previously [21]. Briefly, following
treatment of melanoma cells for the indicated time periods with or
without EGCG or any other agent, the cells were harvested,
washed with cold PBS and lysed with ice-cold lysis buffer
supplemented with protease inhibitors. Equal amounts of proteins
were resolved on 10% Tris-Glycine gels and transferred onto a
nitrocellulose membrane. After blocking the non-specific binding
sites, the membrane was incubated with the primary antibody at
4uC overnight. The membrane was then incubated with the
appropriate peroxidase-conjugated secondary antibody and the
immunoreactive bands were visualized using the enhanced
chemiluminescence reagents. Equal protein loading was verified
on the membrane after stripping it and re-probed with anti-b actin
antibody.
Assay for NF-kB/p65 activity
Quantitative analysis of NF-kB/p65 activity was performed
using the NF-kB Trans
AM Activity Assay Kit (Active Motif,
Carlsbad, CA) following the manufacturer’s protocol. Briefly, the
nuclear extracts of cells were prepared using the Nuclear
Extraction Kit (Active Motif, Carlsbad, CA) following the
manufacturer’s instructions. Absorbance was recorded at
450 nm using absorbance at 650 nm as the reference. The results
are expressed as the percentage of the optical density of the non-
EGCG-treated control group.
Statistical analysis
For migration assays, the control and EGCG-, TPA- PGE2-o r
EP2- and EP4-agonists treatment groups or combined-treatment
groups separately were compared using one-way analysis of
variance (ANOVA) followed by post hoc Dunn’s test using
GraphPad Prism version 4.00 for Windows, GraphPad Software,
San Diego, California, USA, www.graphpad.com. All quantitative
data for cell migration are shown as mean 6 SD/microscopic
field. In each case P,0.05 was considered statistically significant.
Results
Effect of green tea catechins on human melanoma cell
migration/invasion
In the present study, first we have assessed and compared the
effect of various green tea catechins on the invasive potential of
human melanoma cells in vitro using Boyden chamber. The
molecular structures of five major tea catechins, EC, GC, ECG,
EGC and EGCG are shown in Figure 1A. Using in vitro cell
invasion assay, we found that treatment of A375 and Hs294t cells
with equimolar concentration (25 mM) of catechins for 24 h
resulted in inhibition of migration/invasion of these cells. The
relative inhibitory effect of catechins on melanoma cell migration
or invasion was in the order of: EGCG.EGC.ECG.GC.EC,
as shown in Figure 1B. The experiment was repeated three times
and resultant data of cell migration from each treatment group has
been summarized in Figure 1C. These results also suggest that the
cell migration ability of BRAF-mutated A375 cells was higher than
non-BRAF-mutated Hs294t cells; however, the difference was not
statistically significant. This screening preliminary experiment
revealed that EGCG has greater inhibitory effect on melanoma
cell migration compared to other tea catechins; therefore, EGCG
was selected for further studies of cell invasion behavior of human
melanoma cells and the molecular mechanisms underlying these
effects.
EGCG inhibits human melanoma cell invasion
Next, we determined dose-dependent effect of EGCG on the
cell migration potential of A375 and Hs294t human melanoma
cells using Boyden chamber cell migration assays. First, screening
experiments were performed to determine the effects of lower
concentrations of EGCG (mg/mL), which should not reduce the
cell viability or induce apoptosis in these cells. As shown in
Figure 2A, relative to untreated control cells, treatment of cells
with EGCG at concentrations of 0, 10, 20 and 40 mg/mL reduced
the invasive potential of A375 and Hs294t cells in a concentration-
dependent manner. The density of the migrating cells on the
membrane after staining with crystal violet is shown in Figure 2A,
and the numbers of migrating cells/microscopic field are
summarized in Figure 2B. The melanoma cell invasion potential
was inhibited by 13% to 65% (P,0.01–0.001) in A375 cells and by
7% to 70% (P,0.001) in Hs294t cells in a concentration-
dependent manner after treatment with EGCG for 24 h. The
density of cell migration was higher after 48 h, and the inhibitory
effect of EGCG on melanoma cells migration was also
comparatively higher than 24 h (data not shown). To verify that
the inhibition of cancer cell migration by EGCG was a direct effect
on migration ability, and that was not due to a reduction in cell
viability, a trypan blue assay was performed using cells that were
treated identically to those used in the migration assays. Treatment
of A375 and Hs294t cells with various concentrations of EGCG (0,
10, 20 and 40 mg/mL) for 24 h had no significant inhibitory effect
on cell viability or cell death (data not shown).
We have further confirmed the inhibitory effect of EGCG on
melanoma cell migration by employing scratch or wound healing
assay, as described in Material and Methods. As shown in
Figure 2C, relative to untreated control cells, treatment of cells
with EGCG (10 and 20 mg/mL) reduced the migration capacity of
A375 and Hs294t cells in a concentration-dependent manner after
the treatment of cells for 48 h. The part of gap or wounding space
between cell layers after making a wound was occupied by the
migrating Hs294t cells which were not treated with EGCG.
However, the healing of the wound or the empty space of the cells
was not occupied by the migrating cells treated with EGCG and
this effect was dose-dependent. The gap or wounding space
between the cell layers is highlighted by broken white lines, as
shown in Figure 2C. Similar inhibitory effects of EGCG on cell
migration using scratch assay was also found with A375 cells
(Figure 2C, lower panels). These observations suggest that EGCG
has the ability to inhibit the migration ability of melanoma cells.
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melanoma cells
To examine whether the inhibitory effect of EGCG on the
migration of the melanoma cells is associated with the reduction
of endogenous expression of COX-2, we determined the levels of
COX-2 in cell lysates of the various treatment groups using
western blot analysis. Western blot analysis revealed that the
treatment of A375 and Hs294t cells with EGCG reduced the
levels of COX-2 expression in a concentration-dependent
manner as compared to the expression in untreated controls
(Figure 3A).
Celecoxib, a selective COX-2 inhibitor, inhibits melanoma
cell migration
This experiment was performed to verify whether the
inhibitory effect of EGCG on melanoma cell migration is
mediated through its inhibitory effect on COX-2 expression.
For this purpose, equal numbers of A375 and Hs294t cells were
subjected to the cell invasion assay after treatment with various
concentrations of celecoxib (0, 5, 10, 20 mM), a well known
inhibitor of COX-2, for 24 h. As shown in Figure 3B, treatment
of the A375 and Hs294t cells with celecoxib resulted in a
significant reduction in the cell migration capacity of melanoma
cells in a concentration-dependent manner as compared with
non-celecoxib-treated controls (P,0.05–0.001). These data
suggested that the inhibition of COX-2 expression by the
treatment of cells with EGCG is associated with the inhibition
of melanoma cell migration.
EGCG inhibits TPA (an inducer of COX-2)-induced cell
migration
TPA is a well known skin tumor promoter and has been
shown to stimulate the expression of COX-2 in the skin cells
[22]; therefore, the melanoma cells were treated with TPA for
Figure 1. Comparative effects of green tea catechins on the cell invasion capacity of melanoma cells. (A) Chemical structures of major
green tea catechins. EC, (-)-epicatechin; GC, (-)-gallocatechin; ECG, (-)-epicatechin-3-gallate; EGC, (-)-epigallocatechin, and EGCG, (-)-epigallocatechin-
3-gallate. (B) Effect of equimolar concentration (25 mM) of various green tea catechins on the migration of human melanoma cells (A375 and Hs294t)
after treatment for 24 h. (C) The migrating cells were counted and the results expressed as the mean number of migratory cells 6 SD/microscopic
field. Data collected from three independent experiments. Significant inhibition by EGC and EGCG versus non-tea catechins-treated controls,
"P,0.01;
*P,0.001.
doi:10.1371/journal.pone.0025224.g001
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determined the effect of TPA on the migration of melanoma
cells. As shown in Figure 3C, treatment of A375 cells with TPA
(40 ng/mL) for 24 h resulted in a significantly enhanced cell
migration (P,0.001) compared to non-TPA-treated control
cells. To determine whether EGCG inhibits TPA-induced cell
migration in human melanoma cells, A375 cells were treated
with TPA (40 ng/mL) with and without the treatment of
EGCG for 24 h. The treatment of A375 cells with EGCG (20
and 40 mg/mL) resulted in a dose-dependent inhibition of
TPA-induced cell migration. A summary of the cell migration
data for the various treatment groups is provided in Figure 3C.
Treatment of EGCG at the doses of 20 mg/mL and 40 mg/mL
inhibited TPA-induced cell migration by 95% (P,0.001) and
.100% (P,0.001) respectively. To verify whether this
inhibition of cell migration by EGCG is mediated through
the inhibition of TPA-induced COX-2 expression, cell lysates
were prepared and subjected to western blot analysis to
estimate the levels of COX-2 expression. Western blot analysis
data revealed that treatment of A375 cells with TPA for 24 h
resulted in higher expression of COX-2 as compared to the
expression in cells that were not treated with TPA (Figure 3D).
Pretreatment of A375 cells with EGCG (20 and 40 mg/mL) for
24 h resulted in inhibition of TPA-induced COX-2 expression
Figure 2. EGCG inhibits melanoma cell invasion/migration. (A) Treatment of human melanoma cells with EGCG for 24 h inhibits migration of
A375 and Hs294t cells in a concentration-dependent manner. (B) The migrating cells were counted and the results expressed as the mean number of
migratory cells 6 SD/microscopic field. Significant inhibition by EGCG versus non-EGCG-treated controls,
"P,0.01;
*P,0.001. (C) Scratch or wound
healing assay was performed to assess the effect of EGCG on the migration of A375 and Hs294t melanoma cells. Incubation of A375 or Hs294t cells
with EGCG (10 and 20 mg/mL) for 48 h inhibits migration of cells compared to non-EGCG-treated control cells. Assay was repeated three times and
representative pictures are shown. Space between dotted lines in each panel shows the space without or negligent number of migrating cells.
doi:10.1371/journal.pone.0025224.g002
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cell migration by EGCG is mediated through the downregu-
lation of COX-2 expression.
Inhibition of melanoma cell migration by EGCG is
mediated through its inhibitory effects on PGE2
production
PGE2 is one of the metabolites of COX-2, and most of the
biological activities of COX-2 are mediated through its metabo-
lites, therefore, we examined whether treatment of melanoma cells
with EGCG reduced the levels of PGE2 production. For this
purpose, Hs294t melanoma cells were treated with EGCG for
24 h. Cells were harvested and the levels of PGE2 were
determined using PGE2 immunoassay kit. As shown in
Figure 4A, treatment of cells with EGCG resulted in a dose-
dependent reduction in the levels of PGE2 in these cells. Next, we
examined the effect of PGE2 on the Hs294t cell migration using in
vitro cell invasion assay. Cell invasion data revealed that treatment
of PGE2 significantly enhanced (P,0.01, P,0.001) the cell
migration potential in a dose-dependent manner (Figure 4B).
Further, the effect of EGCG on PGE2-induced cell migration was
evaluated. For this purpose, Hs294t cells were treated with PGE2
(10 mM) with and without the treatment with EGCG for 24 h and
cell migration determined. We found that the treatment of
melanoma cells with PGE2 resulted in a significant increase of cell
migration (P,0.05) compared to the cells which were not treated
with PGE2 (Figure 4C and 4D). Treatment of Hs294t cells with
EGCG (20 or 40 mg/mL) for 24 h resulted in a dose-dependent
inhibition of PGE2 (10 mM)-induced melanoma cell migration, as
shown in Figure 4C and data are summarized in Figure 4D.
Similar inhibitory effect of EGCG was observed on PGE2-induced
cell migration in A375 melanoma cells (data not shown).
EGCG decreases the levels of PGE2 receptors in
melanoma cells
COX-2 metabolite PGE2 has been shown to manifest its
biological activity via four known G-protein-coupled receptors (i.e.,
EP1-EP4) [7,23]. Therefore, we determined the effect of EGCG
on the basal levels of PGE2 receptors in melanoma cells. Western
blot analysis revealed that treatment of A375 cells with EGCG (0,
Figure 3. EGCG inhibits invasion of melanoma cells by reducing endogenous COX-2 expression. (A) Treatment of A375 and Hs294t cells
with EGCG for 24 h resulted in down-regulation of COX-2 protein expression. (B) Treatment of A375 and Hs294t cells with celecoxib, an inhibitor of
COX-2, for 24 h inhibits melanoma cell migration in a dose-dependent manner. The data are expressed as the mean number of migratory cells6 SD/
microscopic field. Significant difference versus non-celecoxib-treated control cells,
*P,0.001;
{P,0.05. (C) Treatment of A375 cells with EGCG (20 and
40 mg/mL) inhibits TPA (a COX-2 stimulator)-enhanced cell migration capacity. The data on cell migration capacity are summarized in terms of mean
number of migrating cells/microscopic field 6 SD, n=3. Significant inhibition versus TPA treatment alone,
*P,0.001. (D) EGCG down regulates TPA-
induced COX-2 expression in A375 cells. The levels of COX-2 were determined in cell lysates using western blot analysis.
doi:10.1371/journal.pone.0025224.g003
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reduction in the levels of EP2 and EP4 (Figure 5A). The inhibitory
effect of EGCG was also observed on EP1 and EP3 but was less
prominent than the effect on EP2 and EP4 (data not shown).
An EP2 agonist and EP4 agonist promote the migration
of melanoma cells while EGCG inhibits EP2 and EP4
agonists-stimulated cell migration
To determine whether PGE2 receptor EP2 and EP4 has a role
in melanoma cell migration, and whether EGCG inhibits their
effects on cell migration, we further conducted cell invasion
experiments with A375 melanoma cells. In vitro cell invasion
experiments revealed that treatment of A375 cells with EP2
agonist (butaprost) significantly enhanced the migration ability of
melanoma cells, as shown in Figure 5B. A summary of number of
migrating cells/microscopic field is also shown (Figure 5B, right
panel). Pretreatment of A375 cells with EGCG inhibits EP2
agonist (1 mM)-induced melanoma cell migration by 36% and
58% (P,0.001) at the dose of 20 and 40 mg/mL, respectively
(Figure 5C right panel). Similarly, the effect of EP4 agonist was
determined on the migration of A375 melanoma cells. As shown in
Figure 5D, EP4 agonist treatment of A375 cells for 24 h
significantly enhanced (P,0.001) the cell migration in a dose-
dependent manner. Treatment of cells with EGCG (20 and
40 mg/mL) significantly inhibited (41–66%, P,0.01 and P,0.001)
EP4 agonist-induced cell migration (Figure 5E, left and right
panels). These data suggest that the expressions of PGE2 receptors
in melanoma cells have roles in cell migration, and that EGCG
inhibits the migration of melanoma cells, at least in part, by
decreasing the levels of PGE2 receptors.
EGCG decreases the nuclear level and activity of NF-kB/
p65 in melanoma cells: NF-kB acts as a mediator of
melanoma cell invasion
NF-kB is an upstream regulator of COX-2, therefore we
assessed whether EGCG also affects the levels and activation of
NF-kB in melanoma cells. To examine this effect, A375 cells were
treated with various concentrations of EGCG (0, 10, 20 and
40 mg/mL) for 24 h, and thereafter cells were harvested and cell
lysates prepared for western blot analysis. Western blot analysis
Figure 4. EGCG inhibits PGE2-induced melanoma cell migration. (A) Dose-dependent effect of EGCG on the levels of PGE2 in melanoma
Hs294t cells. The levels of PGE2 are expressed in terms of pg/mg protein6 SD, n=3 independent experiments. Significant inhibition by EGCG versus
non-EGCG-treated controls,
*P,0.001. (B) Treatment of Hs294t cells with PGE2 enhances cell migration in a concentration-dependent manner.
Significant difference versus control,
"P,0.05,
*P,0.001. (C) Treatment of cells with EGCG (20 and 40 mg/mL) inhibits PGE2-enhanced cell migration
capacity of Hs294t cells. Representative photomicrographs of cell migration were presented from three independent experiments. (D) The data on
cell migration are summarized as a mean number of migratory cells 6 SD/microscopic field. Significant inhibition versus PGE2 alone:
*P,0.001. Cell
invasion assays under each experiment were repeated three times and in each case the migrating cells were counted and the results are expressed as
a mean number of migratory cells 6SD/microscopic field.
doi:10.1371/journal.pone.0025224.g004
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translocation of NF-kB/p65 in to the nucleus in a dose-dependent
manner (Figure 6A). The activity of NF-kB also was significantly
reduced (20–65%, P,0.001) after the treatment of cells with
EGCG in a concentration-dependent manner (Figure 6B). The
results also indicated that treatment of EGCG resulted in the
downregulation of IKKa and degradation of IkBa (Figure 6A),
which leads to the inactivation of NF-kB and its translocation to
Figure 5. EGCG inhibits PGE2 receptors-induced human melanoma cell migration. (A) Treatment of A375 melanoma cells with EGCG for
24 h decreases the expression levels of PGE2 receptors EP2 and EP4 in a concentration-dependent manner. The cells were harvested 24 h after the
treatment and cell lysates were prepared and subjected to western blot analysis, as detailed in Materials and Methods. (B) Treatment of A375 cells
with EP2 agonist (butaprost) for 24 h enhances melanoma cell migration (left panels). The data on cell migration are summarized and expressed as a
mean number of migratory cells 6 SD/microscopic field, n=3 (right panel). (C) Treatment of A375 cells with EGCG inhibits EP2 agonist (1.0 mM)-
induced melanoma cell migration (left panels). The data on cell migration are summarized as a mean number of migratory cells 6 SD/microscopic
field, n=3 (right panel). (D) Treatment of A375 cells with EP4 agonist (Cay10580) for 24 h enhances cell migration (left panels). The data on cell
migration in each group are expressed as a mean number of migratory cells 6 SD/microscopic field, n=3 (right panel). (E) Treatment of A375 cells
with EGCG inhibits EP4 agonist (1.0 mM)-induced cell migration (left panels). The data on cell migration are summarized as a mean number of
migratory cells 6 SD/microscopic field, n=3 (right panel). Representative photomicrographs of cell migration were presented from three
independent experiments in each case. Significant inhibition versus non-EGCG-treated controls,
"P,0.01;
*P,0.001; Significant increase versus non-
EP2 agonist-treated or non-EP4 agonist-treated controls,
{P,0.001.
doi:10.1371/journal.pone.0025224.g005
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melanoma cell migration, A375 melanoma cells were treated with
caffeic acid phenethyl ester (0, 5.0 and 10.0 mg/mL), a potent
inhibitor of NF-kB, and cell migration was studied. As shown in
Figures 6C and 6D, treatment of A375 cells with caffeic acid
phenethyl ester resulted in a significant reduction of cell migration
(26% and 57%; P,0.05, and P,0.001) compared to non-cafeic
acid phenethyl ester-treated control cells, and these results are
similar to that observed on treatment of the cells with EGCG
(Figure 2).
EGCG reverses epithelial-to-mesenchymal transition in
melanoma cells
Activation of NF-kB has been implicated in inflammation-
induced tumor growth and progression, and has been identified
as an important regulator of EMT in several cancer cell types
[24–27]. As the inhibition of melanoma cell migration by EGCG
is associated with the inactivation of NF-kB, we sought to
examine whether EGCG targets EMT biomarkers or whether
EGCG transforms mesenchymal biomarkers to epithelial bio-
markers in melanoma cells and that is responsible for its
inhibitory effect on cell migration. To examine this effect, A375
cells were treated with EGCG for 24 h, and cell lysates were
prepared for the analyses of various epithelial and mesenchymal
biomarkers using western blot analysis. As shown in Figure 7,
western blot analyses revealed that EGCG increased the levels of
the epithelial biomarkers, such as E-cadherin, keratin-18 and
desmoglein 2 dose-dependently in melanoma cells compared to
untreated controls. In contrast, the levels of mesenchymal
biomarkers, such as vimentin, fibronectin and N-cadherin were
reduced in melanoma cells after treatment with EGCG in a dose-
dependent manner.
Figure 6. Effect of EGCG on NF-kB activation in melanoma cells. (A) Treatment of A375 cells with EGCG decreases the basal level of NF-kB/
p65 and IKKa while inhibiting the degradation of IkBa. After 24 h treatment with various concentrations of EGCG the cells were harvested and
cytosolic and nuclear fractions were prepared and subjected to the analysis of NF-kB, IKKa and IkBa using western blot analysis. Representative blot
is shown from three independent experiments with identical observations. (B) The activity of NF-kB/p65 in the nuclear fraction of the cells after
treatment with and without EGCG for 24 h was measured using NF-kB/p65-specific activity assay kit, n=3. Activity of NF-kB is expressed in terms of
percent of control (non-EGCG-treated) group. Significant decrease versus control:
*P,0.001. (C) Treatment of A375 cells with caffeic acid phenethyl
ester (CAPE), an inhibitor of NF-kB, inhibits melanoma cell migration. Representative photomicrographs are shown from three separate experiments.
(D) Data on cell migration capacity are summarized as the mean number of migratory cells 6 SD/microscopic field, n=3. Significant inhibition versus
non-CAPE-treated cells:
"P,0.05;
*P,0.001.
doi:10.1371/journal.pone.0025224.g006
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Melanoma remains the leading cause of death from skin disease,
in large part, due to its propensity to metastasize. Although
melanoma is less common than non-melanoma skin cancers,
which includes squamous cell and basal cell carcinoma, however,
it causes approximately 75% skin cancer-related deaths. World
Health Organization report indicated 48,000 melanoma-related
deaths worldwide per year [28]. Most patients suffering from
malignant melanoma ultimately die of their disease within two
years [29,30]. The development of new treatment options and
novel strategies are required which can prevent the invasiveness of
melanoma cells and that can inhibit the metastatic ability of
melanoma cells. Majority of cancers over-express COX-2, an
enzyme responsible for the biosynthesis of PGs metabolites.
Enhanced production of PGs, and particularly PGE2, has been
linked with tumor progression, invasion and metastasis [5,7].
Because of its important role in tumor invasion and metastasis,
COX-2 is considered as a promising target for cancer therapy
[7,31]. Therefore, the search of novel and non-toxic inhibitors of
COX-2 as well as the inhibitors of PGE2 may provide a better
option for the treatment of malignant melanoma and that may
prove a better strategy for its prevention or treatment.
Green tea polyphenols/catechins have been shown to have anti-
carcinogenic activities in various tumor models, including skin
cancers [4,10,14]. In the present study, we have found that EGCG
has significantly greater anti-invasive activity in melanoma cells
compared to EC, GC, ECG and EGC. The significant findings of
the present study are that the treatment of melanoma cells with
EGCG for 24 h inhibits cell migration in a dose-dependent
manner, and that is associated with the inhibition of COX-2
expression and PGE2 production. Based on our experimental
observations, cells will go under apoptosis or cell death if
melanoma cells are treated with higher concentrations of EGCG
or for more than 24 h. Under these conditions, cell migration will
decrease, and this reduction in cell migration could be due to cell
death and not due to changes in migrating behavior of cells. In this
study, cell death or apoptosis is not a reason of EGCG-caused
inhibition of melanoma cell migration. The melanoma cells over-
express COX-2, and the reduction in the levels of COX-2 by
EGCG may be responsible for the inhibition of cell migration of
melanoma cells. This notion is supported by the evidence that
treatment of the melanoma cells with a potent COX-2 inhibitor
(celecoxib) resulted in a reduction of cell migration. Studies have
shown that TPA promotes COX-2 expression and subsequently
enhances cell migration [32], and we have found that TPA-
induced cell migration was blocked by the treatment of cells with
EGCG. These observations further suggest that inhibition of
melanoma cell migration by EGCG is mediated through the
inhibition of COX-2 expression. PGE2 exerts its biologic functions
through four G protein-coupled receptors, EP1, EP2, EP3 and
EP4 [7,23,33], that can stimulate cell survival signals as well as
invasive potential of cancer cells [34–36]. PGE2 has been shown to
promote lung cancer and melanoma cell migration, and that this
effect of PGE2 is associated with the activation of PGE2 receptors
[32,37]. Based on these investigations, we determined the
involvement of the PGE2 receptors in EGCG-mediated inhibition
of melanoma cell migration. It was found that the levels of EP2
and EP4 were decreased when melanoma cells were treated with
EGCG. These data suggest that inhibition of the EP2 and EP4
levels by EGCG may contribute to the inhibition of melanoma cell
migration. The inhibitory effect of EGCG on melanoma cell
migration through the inhibitory effect on EP2 or EP4 was further
verified by treating the cells with an EP2 agonist (butaprost) and an
EP4 agonist (cay10580) with and without the treatment of cells
with EGCG. Our data revealed that the treatment of A375 cells
with the EP2 agonist and EP4 agonist resulted in enhanced cell
migration, and that EP2 agonist- and EP4 agonist-induced cell
migration was significantly inhibited by the treatment of cells with
EGCG using identical in vitro conditions. These observations
support the evidence that inhibition of PGE2 receptors by green
tea catechin EGCG may have contributed to the blocking of
melanoma cell migration. These findings also demonstrate the
feasibility of using EGCG as an alternative to COX-2 inhibitors,
which show toxicity in some patients, given the fact that COX-2
remains an attractive target for cancer therapy. As EGCG acts by
decreasing the expression of both COX-2 and EP receptors, this
could be more effective because EGCG targets both ligand (PGE2)
and receptor (EP). EGCG has also been shown to inhibit
mammary cancer cell migration through the inhibition of nitric
oxide and nitric oxide-mediated mechanisms [38]. Other
phytochemicals also have been assessed for their inhibitory effect
on cancer cell invasion and migration. Punathil and Katiyar [39]
have reported that treatment of non-small cell lung cancer cells
with proanthocyanidins from grape seeds resulted in inhibition of
Figure 7. Treatment of melanoma cells with EGCG results in mesenchymal-to-epithelial transition. Treatment of A375 cells with EGCG
for 24 h enhances the levels of epithelial biomarkers in the cells, such as, the levels of E-cadherin, keratin-18 and desmoglein 2. Simultaneously the
levels of mesenchymal biomarkers in melanoma cells, such as, vimentin, fibronectin and N-cadherin were decreased dose-dependently. Western blot
analysis was performed as detailed under Materials and Methods. Representative blots are shown from three independent experiments with similar
results.
doi:10.1371/journal.pone.0025224.g007
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guanylate cyclase pathways.
As NF-kB is an upstream regulator of COX-2, we further
checked the effect of EGCG on the levels of NF-kB/p65 in
melanoma cells using western blot analysis. EGCG inhibits the
activation of NF-kB/p65 in a dose-dependent manner. Caffeic
acid phenethyl ester, an inhibitor of NF-kB, inhibits melanoma
cell migration. These observations further support the hypothesis
that the inhibitory effect of EGCG on melanoma cell migration is
mediated, at least in part, through the downregulation of COX-2,
PGE2 and PGE2 receptors. However, it remains to be examined
whether down-regulation of other NF-kB target genes also
contribute to the inhibition of invasive potential of melanoma
cells. NF-kB regulates a wide spectrum of biological processes,
including inflammation, cell proliferation and apoptosis. Addi-
tionally, NF-kB has a role in tissue invasion, cancer cell migration
and metastasis. Importantly, NF-kB has been identified as an
important regulator of EMT in several cancer cell types [24–27].
EMT has been shown to play a major role in invasion and
metastasis of epithelial tumors. EMT can render tumor cells
migratory and invasive following its effect on all stages, which
includes invasion, intravasation and extravasation [19]. During
EMT, cells can change from an epithelial to a mesenchymal state.
They lose their characteristic epithelial traits and instead acquire
properties of mesenchymal cells. This process is primarily
coordinated by the disappearance or loss of epithelial biomarkers
such as E-cadherin and certain cytokeratins with the concomitant
appearance of mesenchymal markers such as vimentin, fibronec-
tion and N-cadherin, etc. In the present study, we found that
treatment of melanoma cells with EGCG resulted in suppression
of mesenchymal biomarkers, such as vimentin, fibronectin and N-
cadherin while restored the levels of epithelial biomarkers such as,
E-cadherin, keratin and desmoglein 2, in melanoma cells which
suggest that EGCG has the ability to transform mesenchymal
characteristics to epithelial characteristics in melanoma cancer
cells and this transition may also be one of the possible
mechanisms through which EGCG reduce the invasiveness of
melanoma cells and that lead to inhibition of migration of
melanoma cells in our system.
Together, the results from this study have identified for the first
time that EGCG, a major component of green tea catechins or
polyphenols, inhibit the invasive potential of melanoma cells and
that involves: (i) the inhibitory effect of EGCG on endogenous
COX-2 expression and successive down-regulation of PGE2 and
PGE2 receptors, (ii) the inhibitory effect of EGCG on the
activation of NF-kB/p65, which is the upstream regulator of
COX-2, and (iii) the mesenchymal-to-epithelial transition. Further
mechanism-based in vivo studies are required which can establish
the importance of EGCG and its development as a pharmaco-
logically safe non-toxic agent for the treatment of malignant
melanoma by using either alone or in combination with other
phytochemicals or anti-metastatic drugs.
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